Deciphera Pharmaceuticals, Inc.

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), relating to its proposed merger with ONO Pharmaceutical Co., Ltd. Under the terms of the agreement, ONO will acquire all outstanding shares of Deciphera common stock for $25.60 per share in cash through a tender offer.

To receive more information regarding the investigation of Deciphera Pharmaceuticals, Inc. please fill out the form below.